Key Takeaways
- Resilient quarter despite headwinds: PAT rose ~10% QoQ to ₹32.1 crore even as raw material and freight volatility disrupted demand timing, with specialty-chemical barriers protecting margins.
- Textiles drove volume, hygiene slipped: Textile volumes grew ~14-15% QoQ while health and hygiene volumes fell 10-15% as FMCG customers paused for portfolio resets; exports climbed to ~30% of revenue.
- A new pricing model is being tested: The "fixed-fare" approach guarantees fabric outcomes for a set price per kilo, shifting the customer conversation from input cost to total cost control.
- Acquisition is close but uncommitted: Management is in advanced-stage diligence on a profitable, non-distressed target and has ₹342.55 crore of fresh funds ready, but gave no timeline.
- What to watch next quarter: Whether the promised H2 demand pickup materialises across all divisions, the pace of Ambernath Phase 1 commissioning, and any acquisition announcement.
Demand & Volume Dynamics
- Textile division the bright spot: Volume growth of 14-15% QoQ and 17-18% YoY came from core specialty chemicals, with exports to Bangladesh picking up and international show participation (Vietnam, Bangladesh) generating new leads.
- Health & hygiene hit by customer resets: Volumes fell 10-15% with lower realisations because FMCG customers are rebuilding portfolios and launching new products, creating slackness during brand and recipe changeovers; rural detergent uptake also remains weak.
- Export mix shift underway: Exports rose to ~30% of revenue from ~24-25%, driven by textile chemicals and the first-ever quarter of oil and gas specialty chemical exports to multiple countries.
- Higher-purity products for export: Export orders require higher-purity formulations, so volumes may not rise in lockstep with revenue because the company ships concentrated product to save freight cost, making product mix a fluctuating variable.
- H2 seasonality is the base case: Historically H2 is always better than H1 because the monsoon dampens textile and detergent chemical demand; management expects that pattern to hold and sees positivity across all businesses.
Tibrewala: "Generally, what happens is there is a trend which continues for six months. If it's going down, it's going down for six months. If it's going up, it's going up for six months minimum. However, this was the time when we are seeing fluctuations, like, one week, you start booking your products and raw materials. By the next week, you will see that it's gone up or it's gone down."
Margin Resilience & Input Volatility
- Specialty-chemical moat held: Despite unprecedented week-to-week swings in freight, basic chemical prices and the US dollar, the company maintained EBITDA margins of ~25% and gross margins of 35-40%, a pattern management says has held for 54 listed quarters with EBITDA never below 18%.
- Raw material prices erratic: Prices rose in August, fell, then rose again; the current trend is upward, but the normal six-month directional trend has broken down, making purchase timing unpredictable.
- Freight and container shortages added cost: Freight costs from China and other origins increased, compounded by a container shortage that further pressured landed input costs.
- R&D spend steady in absolute terms: R&D outflows of ₹7-8 crore continue, though the percentage of revenue has declined as the topline grew ~40% YoY over the last 2-3 years; the company holds the highest number of ZDHC and GOTS-approved products (250+) globally, ahead of European multinationals at 150-200.
Tibrewala: "Luckily, as you know, we are into speciality chemicals. And for the last 54 quarters of being listed, you might have seen our EBITDA have always been at least 18% for any of the quarters from 2011 from the time we have got listed."
The Fixed-Fare Model
- A shift from input-selling to outcome-guarantee: The company now offers textile customers a complete package guarantee, taking unfinished fabric to finished using its own recipes for a fixed price per kilo or meter, regardless of chemical dosage.
- Eliminates the blame game: Under the traditional model, chemical suppliers and mills blamed each other when fabric outcomes failed; the fixed-fare approach makes Fineotex solely responsible for the result, which management says increases customer satisfaction by controlling their cost.
- Early stage, no revenue split disclosed: The model was described qualitatively; no data was provided on how much revenue or volume currently runs through it or what margins it carries versus the traditional product-sale model.
Tibrewala: "Instead of, like the taxi meter, we are doing a fixed fare approach in which they are more satisfied about their cost."
Oil & Gas: Early Exports, Big Ambition
- First export quarter achieved: The company exported oil and gas specialty chemicals to various countries for the first time this quarter, a milestone after its ADIPEC 2024 participation in Abu Dhabi.
- NDAs with large oil companies: Management disclosed it is under non-disclosure agreements with certain big oil companies, announcing product lines and developing tie-ups, though no names or revenue contributions were shared.
- Geopolitical demand tailwind: Russian demand is looking to India as a supplier, and management expects oil and gas product demand to flow from other countries to India, calling the segment "very exciting."
- Technical textiles add a defence angle: Geopolitical situations are driving demand for technical textiles (defence applications) where key players are Turkey, Pakistan and Brazil; Fineotex is strong in water repellent, blood repellent and moisture management chemistries.
Acquisition: Advanced Talks, No Clock
- Advanced-stage diligence underway: Documentation, due diligence, legal and finance work is in progress for a target company; funds of ₹342.55 crore from the recent raise are ready alongside strong internal accruals.
- Target profile is specific: Management wants fungible companies with similar ROC/ROE and EBITDA margins to Fineotex, plants already up and running with good margins and profits (not distressed assets), ideally with succession issues that create a willing seller, and clear cross-selling opportunities.
- No timeline commitment: When asked whether an update could come in Q4 FY25 or Q1 FY26, management declined to commit to any quarter, emphasising discipline and caution.
- The cost of a bad deal is measured in years: Management framed acquisition risk not just in money lost but in time lost from the specialty chemical cycle, a constraint that shapes its deliberate pace.
Tibrewala: "We would never like to buy distressed assets or anything like that because we believe that we are not those, with experience of that."
Tibrewala: "If some deal in inorganic acquisition doesn't go well, it's not only you lose money, but you use lose your important 5 years of the -- how do I say, the specialty chemical cycle, I would say. Time is also very much important than money."
Capacity, Credit & People
- Ambernath Phase 1 on track for Q1 FY26: Construction is progressing at good speed; the plant will shift some product lines and machines from Mahape and Navi Mumbai to the new facility for better production cost via faster reaction technology; initial commissioning will take time due to approvals, but incremental capacity additions after Phase 1 will be quicker and cheaper.
- ICRA credit rating upgraded: The upgrade on 11 November strengthens the balance-sheet narrative alongside the completed ₹342.55 crore fund-raise.
- ESOP pool expanding: 25,052 equity shares were allotted under the ESOP 2020 scheme, with 110 employees now included as of 30 September.
- Distributor network growing: The company increased its distributor count and marketing activities, supporting the export push and new geography entries.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Ambernath Phase 1 operational | Shift product lines from Mahape/Navi Mumbai; faster reaction technology for better cost | Beginning of next financial year (Q1 FY26) |
| Promoter warrant payment | Remaining ~₹33-33.5 crore to be paid | Approximately 12 months from now (within 18 months of allotment) |
| Revenue CAGR | At least 28-30% CAGR | Coming couple of years |
| H2 vs H1 performance | H2 "definitely much better" than H1 across all businesses | H2 FY25 |
| Health & hygiene recovery | Will revive "very quickly" | No date; management "not pessimistic" |
| Acquisition announcement | Advanced diligence; funds ready; disciplined approach | No specific quarter committed |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Consolidated revenue | ₹145.7 crore, growth of ~3% compared to Q1 FY2025 |
| Profit after tax | ₹32.1 crore, growth of ~10% compared to Q1 FY2025 |
| PAT margin | 22% |
| EBITDA margin | ~25% |
| Gross margin | 35% to 40% range maintained over last six years |
| Textile division volume growth | ~14% to 15% QoQ and ~17% to 18% YoY |
| Health and hygiene volumes | down ~10% to 15% with lower realizations |
| H1 volumes | ~33,000 to 34,000 tons, largely flattish H1 over H1 |
| Exports share of revenue | ~30%, up from ~24% to 25% |
| R&D budget outflow | ~₹7 crore to ₹8 crore |
| Total fund-raise this year | ₹342.55 crore |
| Fund-raise via preferential allotment | ₹218 crore through equity shares and commodity warrants |
| Promoter participation in fund-raise | ₹45 crore, with ~₹11.5 to 12 crore already paid |
| Products under ZDHC and GOTS ecological approvals | crossed 250 |
| Ambernath Phase 1 capacity | 18,000 to 20,000 tons, expected operational by beginning of next financial year |